- Issuer ticker
-
IMRX
- Reported as of
-
02 Jul 2025
- Net transaction value
-
+$19,862
- SEC form
-
4
- Accepted by SEC
-
07 Jul 2025, 08:59:25 UTC
Filing notes and source
Key filing fact
Diana F. Hausman filed Form 4 for Immuneering Corp (IMRX) on 07 Jul 2025.
Key facts
- This page summarizes Diana F. Hausman's Form 4 filing for Immuneering Corp (IMRX).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 07 Jul 2025, 08:59.
Change
- Previous filing in this sequence was filed on 16 Jun 2025.
- Current net transaction value: +$19,862.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001563992
Primary reporting owner
HAUSMAN DIANA
- Relationship
-
Director
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IMRX
transaction
Class A Common Stock
Purchase
- Transaction value
- $8,989
- Shares
- +2,500
- Change %
- Price
-
$3.60
- Shares after
- 2,500
- Date
- 02 Jul 2025
- Ownership
- Direct
IMRX
transaction
Class A Common Stock
Purchase
- Transaction value
- $10,874
- Shares
- +3,000
- Change %
- Price
-
$3.62
- Shares after
- 3,000
- Date
- 02 Jul 2025
- Ownership
- By spouse
* marks a reported price that did not pass the local price check.